Not applicableNo Longer AvailableNCT04802083What this trial is testingCOVID-19 Soliris Expanded Access ProtocolWho this might be right forCovid19 Alexion Pharmaceuticals, Inc.
Early research (Phase 1)Not Yet RecruitingNCT07377253What this trial is testingFirst-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.Who this might be right forThe Tick-borne Encephalitis Virus (TBEV) Giuseppe Pantaleo 18
Testing effectiveness (Phase 2)Study completedNCT01943305What this trial is testingThe Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in HumansWho this might be right forYellow FeverEncephalitis, Japanese Singapore General Hospital 84
Not applicableStudy completedNCT02669966What this trial is testingLive Kidney Donors With Positive Anti-HCV Antibody, But Negative HCV PCRWho this might be right forESRDHepatitis C University of Florida 2
Early research (Phase 1)UnknownNCT00062530What this trial is testingSafety of an Oral HIV Vaccine in HIV Uninfected VolunteersWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 38
Testing effectiveness (Phase 2)UnknownNCT00089700What this trial is testingTNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1Who this might be right forHIV Infections Tanox 80
Not applicableStudy completedNCT00025922What this trial is testingInfluenza Vaccine in HIV Infection: Immune Response and Effect on Viral LoadWho this might be right forHIV Infection National Institute of Allergy and Infectious Diseases (NIAID) 240
Not applicableStudy completedNCT04471051What this trial is testingAn Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 PatientsWho this might be right forCovid19 University of Colorado, Denver 255
Not applicableStudy completedNCT04734886What this trial is testingThe Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19Who this might be right forCovid19 Örebro University, Sweden 161
Early research (Phase 1)Study completedNCT03618056What this trial is testingEvaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus ErythematosusWho this might be right forHIV InfectionsSystemic Lupus Erythematosus National Institute of Allergy and Infectious Diseases (NIAID) 1
Not applicableEnded earlyNCT05315583What this trial is testingNeutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum AntibodiesWho this might be right forCOVID-19SARS CoV 2 Infection Centre Hospitalier Régional d'Orléans 9
Testing effectiveness (Phase 2)Study completedNCT05077254What this trial is testingCOVID Protection After Transplant-Immunosuppression ReductionWho this might be right forKidney Transplant RecipientsLiver Transplant Recipients National Institute of Allergy and Infectious Diseases (NIAID) 48
Post-approval studies (Phase 4)Study completedNCT00240526What this trial is testingLT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ MothersWho this might be right forHepatitis B GlaxoSmithKline 79
Testing effectiveness (Phase 2)Ended earlyNCT01121185What this trial is testingStudy in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis CWho this might be right forHCV InfectionLiver Transplantation MassBiologics 13
Not applicableUnknownNCT04445415What this trial is testingDiagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare WorkersWho this might be right forCOVID-19 Assiut University 250
Not applicableStudy completedNCT04801758What this trial is testingAnalytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP StudyWho this might be right forHIV Infection HIV Vaccine Trials Network 18
Not applicableStudy completedNCT05067400What this trial is testingSARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV CohortWho this might be right forHIV-1-infectionSARS-CoV InfectionCovid19 Royal Free Hospital NHS Foundation Trust 615
Testing effectiveness (Phase 2)Study completedNCT04871113What this trial is testingEvaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected AdultsWho this might be right forHIV Infections ViiV Healthcare 62
Not applicableActive Not RecruitingNCT07820241What this trial is testingLong-term Immune Persistence of a Bivalent HPV Vaccine in Females From Study 311-HPV-1004Who this might be right forHuman Papillomavirus Infection Shanghai Zerun Biotechnology Co.,Ltd 348
Testing effectiveness (Phase 2)Ended earlyNCT04992273What this trial is testingCOVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of AgeWho this might be right forCOVID-19 Regeneron Pharmaceuticals 7